World Health Organization (WHO) estimated that in 2016, more than 1.9 billion adults, 18 years and older, were overweight. Of these over 650 million were obese. This, together with an unhealthy diet and lack of physical activity are leading global risks to health with pathologies like diabetes, heart disease or stroke. Our last in vivo study shows the beneficial effects of ABG10+® in vascular and metabolic alterations like reducing caloric intake and body weight. For the full article, or via our Linked-IN company webpage.